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Background
Although apps are increasingly being used to support the diag-
nosis, treatment and management of mental illness, there is no
single means through which costs associated with mental apps
are being reimbursed. Furthermore, different apps are amenable
to different means of reimbursement as not all apps generate
value in the same way.
Aims
To provide insights into how apps are currently generating value
and being reimbursed across the world, with a particular focus
on the situation in the USA.
Method
An international team performed secondary research on
how apps are being used and on common pathways to
remuneration.
Results
The uses of apps today and in the future are reviewed, the nature
of the value delivered by apps is summarised and an overview of
app reimbursement in the USA and other countries is provided.
Recommendations regarding how payments might be made for
apps in the future are discussed.
Conclusions
Currently, apps are being reimbursed through channels with
other original purposes. There may be a need to develop an app-
specific channel for reimbursement which is analogous to the
channels used for devices, drugs and laboratory tests.
Declaration of interest
A.P. reports employment by Payer + Provider Syndicate, and
stock ownership of Berkshire Hathaway, Community Health
Systems, CVS Health Corp, HCA Healthcare, Payer + Provider
Syndicate, Quorum Health Corp and Tenet Healthcare Corp. A.P.
is a paidmember of the Scientific Advisory Board of PsyberGuide
and of the Expert’s Council of the Mary Christie Foundation. J.T.
reports research support from Otsuka Pharmaceuticals. J.F. and
K.K. report no competing interests.
Keywords
Health insurance; mHealth; mobile health; smartphones;
managed care; value; apps; digital.
Copyright and usage
© The Author(s) 2020. This is an Open Access article, distributed
under the terms of the Creative Commons Attribution licence
(http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted re-use, distribution, and reproduction in any
medium, provided the original work is properly cited.
The use of apps to support mental healthcare is evolving. As apps
play an expanding role in care, their complexity is in some cases
simultaneously increasing. To cover the costs associated with
more complex apps being used for a diverse set of purposes, app
developers have sought multiple pathways to reimbursement.
International differences in the financing of healthcare have likewise
led to different approaches being pursued in different countries. The
aim of this article is to provide insights into how apps are currently
generating value and being reimbursed across the world, with a par-
ticular focus on the situation in the USA.
Method
An international team performed secondary research on how apps
are being used in the context of mental health and on common path-
ways to remuneration. The team featured members with experience
working in Australia, the UK and the US. Teammembers collabora-
tively developed conclusions based on their findings.
Results
Use of apps today
Today, apps are being used to support the diagnosis, treatment and
management of mental illness in multiple ways. Apps are used in the
context of preventive, acute and even emergency care. There are
over 250 000 health apps available according to industry reports.1
The USA iOS App Store contains over 300 apps to address
anxiety disorder alone.2 Nonetheless, there is no single means
through which costs associated with mental health apps are being
reimbursed.3
Although much remains unknown about exactly who is using
mental health apps, it is clear that many are interested and likely
trying them.4 In 2015, a national survey noted that mental health
apps were in the top three categories of health apps downloaded.5
Apps have the potential to increase access to care for people who
might not otherwise seek professional care, as patients may use
apps independently or be encouraged by apps to seek in-person
help via app-based screening and diagnosis. One of the earliest
examples is a 2014 study that
offered depression screening to over 8000 people across 66 countries
and encouraged those with elevated nine-item Patient Health
Questionnaire scores to seek local help.6 Since then, a plethora of
screening apps have emerged.
Apps can also benefit those already in care. For example, people
who have sought professional care are using apps both to interact
with their healthcare provider via an additional channel, and to
assess and treat their conditions on a standalone basis. This hybrid
approach of integrating apps to augment care has been implemented
at community clinics7 and the Veterans Administration.8
Furthermore, healthcare providers are in some instances using apps
to support administrative aspects regarding the delivery of care,
such as care management and case management.9 Thus, mental
health apps exist along a spectrum – some are used as a complete sub-
stitute for in-person care, and others are used behind the scenes to
support in-person processes. Although many apps today are not
regulated in the USA either because they claim to be wellness tools
(rather thanmedical devices) or are in categories subject to regulatory
discretion, several are pursuing formal US Food and Drug
Administration approval.10
Apps are as diverse in their quality as they are in their purposes.
Reviews of apps on the iTunes and Google Play commercial market-
places suggest that most mental health apps do not follow evidence-
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based guidelines11 and many actually pose privacy risks to patients
using them.12 Nonetheless, there also are evidence-based apps, such
as the IntelliCare apps developed at Northwestern University,13
which stand in contrast to most of the apps available.
Use of apps in the future
The three locations in which apps are used – outside of a clinical
setting, within amental health clinical setting, and within other clin-
ical settings (for example the emergency department, the primary
care physician’s office) – are not likely to change in years to
come. However, the extent, level of integration and level of ubiquity
of app use is likely to increase over time as patient access to smart-
phones only increases and app offerings become more advanced. In
the end state, there will likely not be a distinction made as to
whether apps are employed in the care-delivery process or not, as
they will be viewed as foundational infrastructure and tools, much
like websites are today. Although the initial enthusiasm for apps
has led to speculation that as tools, apps alone may offer effective
self-help, increasing evidence suggests that a more effective use is
towards augmenting and extending clinical care – not replacing
it.14 The quality and evidence-base for apps will also likely
improve. Thus, it makes sense that apps are progressively becoming
part of the infrastructure for healthcare delivery as they assume their
proper role. In the years that unfold, apps will be used for a variety of
population health management applications, enabling healthcare
providers to better manage patients across the continuum of care.
Although patients are able to use apps while at home,many apps
today have little or no integration into the traditional care process,
and as a result may further the fragmentation of care. In the future,
the frequency with which such apps are integrated into traditional
care will likely increase. Informatics standards backed by the
federal government such as FHIR (Fast Healthcare Interoperability
Resource) and SMART15 offer a clear path for this integration. By
all metrics, the role of these health apps will dramatically increase
as apps are created to fill a broader array of needs, apps become
more tightly integrated into the clinical workflow and more evi-
dence regarding the effectiveness of apps becomes available.
Value delivered by apps
Value in healthcare is measured by dividing the outcomes delivered
by an intervention by its cost.16 Apps are being employed in a
diverse set of ways within mental health, and the value that they
deliver to patients, healthcare providers and health plans differs
according to the manner in which they are used and priced.
Patients benefit from apps to the extent to which they improve
the quality of their mental health – either by enabling them to
access screening, diagnosis and treatment that they would otherwise
not receive, or by augmenting the screening, diagnosis and treat-
ment that they do receive. Such augmentation can involve a
diverse range of tools, including apps for implementing measure-
ment-based care, digital therapeutics that may be used at home,
or care/case management software that improves continuity and
coordination of care among healthcare providers. Improved
mental health can in turn lead to savings from improved physical
health, better earnings from enhanced current performance at
work, and potentially higher future earnings because of the progres-
sive nature of many careers. The economic burden of depression,
sadness and mental illness is so large that when its costs are
spread across all employees (not just those who are affected), it
costs employers approximately $300 per employee per year. Thus,
there is large potential savings at stake in addressing mental
illness.17 However, realising return on this investment will not be
immediate and requires a tolerance for longer-term outcomes.
Apps can also potentially reduce many of the direct and indirect
costs associated with care, through enabling services to be delivered
more efficiently, reducing physical health costs associated with
untreated comorbid mental illness, and by reducing the need for
in-person visits and the associated transportation costs. One pro-
gramme found that the savings from reduced hospital admissions
resulting from an app-based mental health initiative were so great
that they more than offset the cost of providing patients with smart-
phones.18 Healthcare providers gain value from apps to the extent
that they increase demand for mental health services, foster
greater use of services (particularly, app-related services, such as
brief assessments), decrease operating costs and improve patient
attendance/engagement.19 Apps deliver value to health plans from
potential savings resulting from substitution for other forms of
care, as well as potential savings from the prevention of higher-
acuity situations as a result of early identification and recognition.20
Still, the majority of health apps today have not demonstrated
value and economic outcomes are sparse.21 A review of top-
funded digital health companies examined the studies supported
by these companies and found that those in mental health and
depression have examined feasibility, but they have not yet exam-
ined clinical effectiveness.22 There have been multiple attempts in
the literature to characterise the value delivered by apps when
used to improve mental health, ranging from a paper that provided
a framework for analyses without numerical findings20 to a system-
atic and meta-review.23 The meta-review considered the findings of
21 reviews, and concluded that there was a lack of evidence regard-
ing the cost-effectiveness of digital health interventions when used
by young people (adults were not explored). A broader systematic
review of the literature, which considered cost-effectiveness and
cost-utility studies of mobile health and telemedicine in all contexts
concluded that the literature is limited and that there are frequently
methodological issues with the analyses that do exist.24 A literature
review that explored whether apps were effective in the context of
mental health found a shortage of evidence, particularly for some
categories of apps.25 In order to conclude whether apps deliver
value, there needs to be first further research into the effectiveness
component of the value equation. This does not mean that health
apps do not generate value, but rather reflects the need formore out-
comes data and real-world experiences using them in actual clinical
settings,26 along with cost-effectiveness analyses.
Regardless of the conclusions of value-related analyses, the adop-
tion ofmental health apps will be impeded if there are not meaningful
reimbursement mechanisms that are visibly available. When confi-
dential, one-off contracts between organisations and app vendors
are used to provide reimbursement, potential vendors do not have
the benefit of seeing the potential financial pay-off of investing in
app development, and some may forego making such investments.
Given the substantial differences in which health services are financed
across nations, it is unlikely that an internationally consistent reim-
bursement mechanism will ever cover the cost of apps.
Nonetheless, if there are clear paths to reimbursement in major
markets, there will be greater market support for app development
activity, and there will be more visible stakeholders towards whom
value-related analyses should be conducted.
App reimbursement in the USA
The cost of apps to patients, healthcare providers and health
insurers differs in accordance with how they are being used. Like
pharmaceuticals, an app has a high development cost, but then
next to no marginal cost to distribute an additional copy. That
said, apps vary in the amount of human time input that they
require: of the patient, of the healthcare provider and of other
members of the care team.
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As a result of this high degree of variation, there aremultiple fra-
meworks that are used to reimburse apps. As is shown in Fig. 1, apps
are reimbursed by health plans via Current Procedural Terminology
(CPT) codes and via channels traditionally intended for devices,
drugs and laboratory tests. One-off direct payment relationships
are also used by health plans, in addition to being used by employ-
ers, healthcare providers and patients that wish to cover the costs of
apps and app-related services. Finally, the costs associated with apps
can be covered using a portion of bundles of funds given by a health
plan to a healthcare provider for a broader purpose. A portion of the
money paid for a CPT codemay be used to cover the cost of an app if
the app helps the healthcare provider deliver the service. Likewise,
capitated payments made by a health plan to a healthcare provider
may be used to purchase apps. A detailed review of the specific CPT
codes being used to reimburse apps in the USA today, as well as the
other channels that are being used to reimburse apps, is presented in
Powell et al, and is outside the scope of this paper.3
The primary means of reimbursing healthcare provider services,
CPT codes, assigns reimbursement to health services based upon a
combination of the physician work, malpractice expenses and prac-
tice expenses, and then adjusts for geographic differences through
the Geographic Practice Cost Index.27 When apps are used in
tight conjunction with physician services, such as situations in
which they are used for administrative purposes, it is quite feasible
for there to be a substantial quantity of physician work required in
addition to malpractice expenses and practice expenses. These
app/service combinations are good targets for CPT-based billing.
However, when apps are used by patients independently, outside
the physician’s office, the amount of physician and staff work
required is often minimal. In these cases, it is harder for their reim-
bursement to be shoehorned into the CPT system because they do
not make substantial use of the resources that are measured when
valuing CPT codes. New CPT codes are emerging that may
support clinician monitoring of remote data generated by apps,
although at the time of writing, it remains unknown if this can be
successfully utilised.28 The CPT codes that are presently available,
99453, 99454 and 99457, are intended for the monitoring of physio-
logical parameters, and are in their present form unsuitable for use
in implementing measurement-based care in the context of
behavioural health. Nonetheless, mental health apps are being
reimbursed as if they were hardware, via the Healthcare Common
Procedure Coding System (HCPCS) codes for miscellaneous
durable medical equipment (E1399) and electronic medication
compliance management devices (T1505).29 Although there are
ongoing efforts and announcements around companies such as
CVS Health offering health apps,30 the use of prescription apps
reimbursed by insurers for use in clinical care remains nascent at
the time of this writing.
Many apps today are direct-to-consumer and require the end
user to pay out of pocket. The sudden closure of the Lantern
mental health app in 2018, which the chief executive officer sug-
gested was because of the company’s decision to pursue direct-to-
consumer markets, offers one striking example of the challenges
of this route.31,32 Nonetheless, out-of-pocket payment has been a
common means of financing apps as it is the simplest approach to
implement and does not require the accumulation of clinical
evidence.
App reimbursement in other countries
The approaches that other countries are taking towards app reim-
bursement varies in accordance with their respective modes of
healthcare financing. In England, where the National Health
Service (NHS) provides services free at the point of use, the govern-
ment is negotiating bulk buy contracts on behalf of health systems.
At least one app has been purchased in bulk using such an arrange-
ment.33 The NHS has additionally created a library of apps, which
are either free, require payment by patients, are offered cost-free
to patients with a general practitioner’s prescription or referral, or
are offered cost-free to patients living and working within specific
geographic areas.34,35
The Australian government runs a website, healthdirect,
intended to provide Australians with free health advice. The
website includes a symptom checker that is intended to assist
Australians in triaging their illnesses. An app-based version of the
site is available for Android and iOS smartphones. The healthdirect
website additionally recommends a number of free apps produced
by the government and third parties.36
A toolkit prepared by theMental Health Commission of Canada
encouraged healthcare providers to consider the costs associated
with apps when recommending them to patients. The toolkit sug-
gests that as alternatives to direct patient payments for apps,
health systems or health plans could pay for apps on a per-user
basis, pay a fixed fee to license unlimited access for a period of
time, pay an access fee or bundle the costs associated with apps
into the overall cost of care billed to self-pay patients.37 These
approaches have also been observed in the USA.
How apps should be reimbursed in the USA in the future
As apps become more autonomous, it becomes more difficult to
tie them to reimbursement methodologies based upon physician
time and practice expenses. Traditionally, devices, drugs and
laboratory tests have been billed using means that do not con-
sider the degree of human involvement in care. Device billing
may occur for the one-time purchase of a device (such as a
cranial electrotherapy stimulation device) or on an ongoing
EmployerHealth plan Healthcare
provider 
Patient
CPT Device-like
Direct
payment 
Lab-like Bundled
payment 
Drug-like
Channel
Source of
reimbursement 
Fig. 1 Sources of app reimbursement in the USA.3 Modified from reference 3. ©AdamCPowell, Matthias B Bowman, Henry T Harbin. Originally
published in JMIR Mental Health (http://mental.jmir.org), 06.08.2019. (An open-access article distributed under the terms of the Creative
Commons Attribution License – https://creativecommons.org/licenses/by/4.0/.)
CPT, Current Procedural Terminology.
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rental basis requiring proof of utilisation (such as a continuous
positive airway pressure machine). Thus, the reimbursement
channels available are amendable to be used for the reimburse-
ment of apps that are used on a standalone, prescription basis
until an app-specific channel for reimbursement is developed.
Currently, while there is a CPT code, 96127, that can be used
for brief behavioural assessments that are conducted by patients
without physician administration, there is no analogous code for
autonomous treatment.29 Likewise, although apps can be billed
as devices via the HCPCS codes E1399 and T1505, these
codes were not designed to be used to cover apps.
Although some app developers have followed these approaches
to reimbursement, pursuing prescription-based reimbursement is a
barrier to both developers and patients. Developers need to receive
approval from the US Food and Drug Administration, and health-
care providers need prescribing authority to provide patients with
access to apps reimbursed through these channels. Such a system
does not take advantage of the unique features and scalability of
tools like apps. As mental health services are often delivered by
people without prescribing authority, including social workers
and psychologists (who lack prescribing authority in many states),
these channels are a barrier to patient access. Professional organisa-
tions such as the American Psychiatric Association and the
American Psychological Association have not yet written practice
guidelines that may help define the roles and scope of app use.
Reducing these barriers for apps used without healthcare provider
involvement will likely play a key role in increasing development
and adoption.
Nonetheless, even those capable of prescribing apps may have
difficulty recommending them. Lack of guidance on standards for
app quality and app-related liability may cause healthcare providers
to hesitate in recommending apps.38 Although physicians are liable
for their drug prescription decisions, liability related to apps is
murkier. To clarify matters and allay professional fears, the UK-
based NHS Apps Library posts the following disclaimer: ‘Any
healthcare professional recommending health apps published on
the NHS Apps Library is not liable for any adverse reactions or a
deterioration in health experienced by users. The liability resides
exclusively with the developers of the product in question and it
is their responsibility to maintain compliance with the relevant reg-
ulations.39 No similar protections are available to American health-
care providers.
Discussion
Apps are playing an increasing role in enabling people to receive
care for mental health issues. Over time, they will become a more
integral component of our healthcare infrastructure, and fewer dis-
tinctions will be drawn between care that is facilitated by an app and
care that is not. However, for apps to fulfil their full potential,
changes need to be made in the reimbursement mechanisms avail-
able for care delivered through apps so that it is more feasible for
app developers to be compensated for the value that they are
providing.
There may be a need to unlink the connection between health-
care provider compensation and time input, and to develop an app-
specific channel for reimbursing apps that is analogous to the chan-
nels used for devices, drugs and laboratory tests. The channel would
consist of a standardised series of HCPCS codes for app-related pro-
cedures that health plans could then adopt and use to compensate
providers for app-related services. Doing this would reduce the
need for the development of one-off contracts. Once these
changes have been implemented, the USA will be able to more
rapidly move towards a future in which apps play a more central
role in mental healthcare, following the example seen in the UK
in the form of the NHS Apps Library.
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